NCT04630327

Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory

Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory Among Female Cancer Patients

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 226 (actual)
• Sponsor: Kazakh Medical University of Continuing Education · Academic / Other
• Sex: Female
• Age: 18 Years – 65 Years
• Healthy volunteers: —

Summary

Depression and anxiety in female patients with cancer are serious comorbidities that affect the quality of life for patients and their survival rates as they have poorer health outcomes. This validation study is a part of the study on the prevalence of depression and anxiety among breast cancer patients. This study aims to investigate the validity of the Kazakh and Russian versions of the Beck Depression Inventory (BDI-II) and Beck Anxiety Inventory (BAI) among female cancer patients in Almaty, Kazakhstan.

Conditions

• Depression
• Anxiety
• Breast Cancer
• Ovarian Cancer
• Cervical Cancer
• Lung Cancer
• Colon Cancer

Interventions

Type	Name	Description
OTHER	Beck Depression Inventory-21 (diagnostic survey)	Kazakh or Russian versions of the Beck Depression Inventory-21will be filled by female cancer patients
OTHER	Beck Anxiety Inventory	Kazakh or Russian versions of the Beck Anxiety Inventory will be filled by female cancer patients
OTHER	Interview using The International Classification of Diseases in tenth edition (ICD-10) criteria	Interview using The International Classification of Diseases in tenth edition (ICD-10) criteria as a gold standard of diagnosing depression or anxiety

Timeline

• Start date: 2020-01-13
• Primary completion: 2022-04-28
• Completion: 2022-05-01
• First posted: 2020-11-16
• Last updated: 2022-06-21

Locations

2 sites across 1 country: Kazakhstan